Related Experiment Video

Updated: Aug 11, 2026

A Functional Whole Blood Assay to Measure Viability of Mycobacteria, using Reporter-Gene Tagged BCG or M.Tb (BCG lux/M.Tb lux)
08:10

A Functional Whole Blood Assay to Measure Viability of Mycobacteria, using Reporter-Gene Tagged BCG or M.Tb (BCG lux/M.Tb lux)

Published on: September 14, 2011

Effect of human newborn BCG immunization on monocyte viability and function at 3 months of age

R L Sepulveda1, S Arredondo, E Rodriguez

  • 1National Institute of Respiratory Diseases and Thoracic Surgery, University of Chile Medical School, Santiago, Chile.

The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease
|April 1, 1997
PubMed

Insights

Bacille Calmette-Guérin (BCG) vaccination boosts infant monocyte viability and mycobacteria uptake but does not improve killing ability in the absence of T-cells. This impacts understanding of BCG

Area of Science:

  • Immunology
  • Microbiology
  • Vaccinology

Background:

  • Bacille Calmette-Guérin (BCG) vaccination is a primary tool against tuberculosis.
  • BCG's immune response involves T-cell immunity and monocyte activation.
  • The impact of BCG on innate monocyte-macrophage function requires further elucidation.

Purpose of the Study:

  • To investigate if newborn BCG immunization enhances the innate capacity of monocyte-macrophages.
  • To assess the ability of cultured monocyte-macrophages to ingest and kill virulent mycobacteria.
  • To determine these effects in the absence of lymphocytes.

Main Methods:

  • Cultured monocyte-macrophages from BCG-immunized infants, non-immunized infants, and BCG-immunized adults were used.
  • Cells were incubated with Mycobacterium tuberculosis.
  • Monocyte-macrophage viability, cell counts, and intracellular bacillary load were assessed over time.

Main Results:

  • BCG-immunized infants and adults showed significantly higher monocyte-macrophage viability after 7 days.
  • Uptake of M. tuberculosis by monocytes was significantly increased in BCG-immunized groups.
  • No enhanced killing of intracellular M. tuberculosis was observed in BCG-immunized individuals.

Conclusions:

  • BCG vaccination enhances monocyte viability and mycobacteria uptake.
  • The enhanced innate response does not translate to improved mycobacterial killing in vitro without lymphocytes.
  • Findings suggest BCG's effect on innate immunity is complex and context-dependent.
Abstract

More Related Videos

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis08:46

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

Published on: August 12, 2020

Mapping Infant Immunity with Minimal Input: Integrative Single-Cell and Multiomic Profiling10:29

Mapping Infant Immunity with Minimal Input: Integrative Single-Cell and Multiomic Profiling

Published on: April 3, 2026

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...